Optimal Performance And Physical Therapies St. Petersburg, Llc - Medicare Physical Therapist in St Petersburg, FL

Optimal Performance And Physical Therapies St. Petersburg, Llc is a medicare enrolled "Physical Therapist" provider in St Petersburg, Florida. Their current practice location is 2600 Dr Martin Luther King Jr St N Ste 200b, St Petersburg, Florida. You can reach out to their office (for appointments etc.) via phone at (727) 474-5580.

Optimal Performance And Physical Therapies St. Petersburg, Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Optimal Performance And Physical Therapies St. Petersburg, Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1073085734.

Contact Information

Optimal Performance And Physical Therapies St. Petersburg, Llc
2600 Dr Martin Luther King Jr St N Ste 200b,
St Petersburg, FL 33704-2744
(727) 474-5580
Not Available



Healthcare Provider's Profile

Full NameOptimal Performance And Physical Therapies St. Petersburg, Llc
TypeFacility
SpecialityPhysical Therapist
Location2600 Dr Martin Luther King Jr St N Ste 200b, St Petersburg, Florida
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1073085734
  • Provider Enumeration Date: 12/19/2018
  • Last Update Date: 12/09/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 1557699212
  • Enrollment ID: O20200107000369

Medical Identifiers

Medical identifiers for Optimal Performance And Physical Therapies St. Petersburg, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073085734NPI-NPPES
PT19911OtherFLPT LICENSE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Optimal Performance And Physical Therapies St. Petersburg, Llc acts as a billing entity for following providers:
Provider NameJeremy Maddox
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1861597577
PECOS PAC ID: 2264611664
Enrollment ID: I20110131000594

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameElissa Deusner
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1922461870
PECOS PAC ID: 8224310313
Enrollment ID: I20170125001785

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameRachel Iaquaniello
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1629597539
PECOS PAC ID: 7517224470
Enrollment ID: I20171130001906

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameDaniel Peterson
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1295211878
PECOS PAC ID: 0547504904
Enrollment ID: I20181212000824

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameTaylor Collins
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1720634595
PECOS PAC ID: 0941530273
Enrollment ID: I20190930000074

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameEmily Elizabeth Srnka
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1154790178
PECOS PAC ID: 8123451119
Enrollment ID: I20191205000792

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameKatherine Williams
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1770197063
PECOS PAC ID: 6800214081
Enrollment ID: I20200921001834

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameZachary Forrest Mayhew
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1013523851
PECOS PAC ID: 8527478213
Enrollment ID: I20201109002051

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameJohn Tyler Briggs
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1316558232
PECOS PAC ID: 5597172072
Enrollment ID: I20210330000315

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameBrent Champagne
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1952878498
PECOS PAC ID: 1052653052
Enrollment ID: I20210519001376

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameAndrea Briana Swope
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1841909538
PECOS PAC ID: 2860861135
Enrollment ID: I20221208000139

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NamePatrick Parker
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1821698101
PECOS PAC ID: 2668882465
Enrollment ID: I20230124002699

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Provider NameLucas Houska
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1699449280
PECOS PAC ID: 9436531571
Enrollment ID: I20230608000034

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Optimal Performance And Physical Therapies St. Petersburg, Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Optimal Performance And Physical Therapies St. Petersburg, Llc
21756 State Road 54 Ste 102,
Lutz, FL 33549-2905

Ph: (727) 475-5580
Optimal Performance And Physical Therapies St. Petersburg, Llc
2600 Dr Martin Luther King Jr St N Ste 200b,
St Petersburg, FL 33704-2744

Ph: (727) 474-5580

News Archive

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

New risk assessment scoring system may help physicians select screening tests for colorectal cancer

Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing for cancer screening and which should receive the test.

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

Read more News

› Verified 7 days ago


Physical Therapist in St Petersburg, FL

Purpose Physical Therapy
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 6619 1st Ave S, St Petersburg, FL 33707
Phone: 417-315-5777    
Mrs. Cynthia Ann Driver Saldanha, PT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 801 6th St S, St Petersburg, FL 33701
Phone: 727-767-8093    Fax: 727-767-4004
Alliance Sports Rehab
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 111 2nd Ave Ne Ste 1401, St Petersburg, FL 33701
Phone: 727-258-7224    
Danielle Marie Wanek, PT, DPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 100 1st Ave N Unit 4201, St Petersburg, FL 33701
Phone: 608-772-7727    
Bao-quyen Nguyen, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 260 1st Ave S Ste 200-161, St Petersburg, FL 33701
Phone: 727-803-1102    
Kimberley D Carson, P.T., D.P.T
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 501 6th Ave S, St Petersburg, FL 33701
Phone: 727-767-6913    Fax: 727-767-6757
Aegis Group Practice Llc
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 3600 34th St S, St Petersburg, FL 33711
Phone: 800-444-6845    Fax: 479-478-2852

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.